Giant
cell tumours (GCT) of the skull base account for approximately 1% of all GTC of
the bone. Despite being considered as a benign neoplasm, they are locally aggressive with high recurrence rates after incomplete
surgery. Due to the small number of cases reported in skull base, standardized treatment remains unclear. Even with new surgical
techniques, a complete resection in skull base tumours is not
always possible without functional compromise. Therefore, adjuvant therapy is
essential to enhance local control and quality of life. We described a case
treated successfully with primary surgery followed by Cyberknife stereotactic radiosurgery (SRS) and denosumab with a 48-month follow-up.
To the best of our knowledge, the usage of combined therapy, SRS and
denosumab, in skull base GCT has not been previously described.
Cite this paper
Guajardo, J. H. , Pena, C. D. L. , Gonzalez, M. F. , Gonzalez, C. , Cuilty, C. and Decanini, H. (2017). Giant Cell Tumour of the Skull Base Treated with Surgery, Stereotactic Radiosurgery and Denosumab: Case Report and Review of Literature. Open Access Library Journal, 4, e3571. doi: http://dx.doi.org/10.4236/oalib.1103571.
Zhao, J., Qian, T., Zhi, Z.,
Li, Q.,
Kang, L.,
Wang, J., et al. (2014) Giant
Cell Tumor of the Clivus: A Case Report and Review of Literature. Oncology Letters, 8, 2782- 2786. https://doi.org/10.3892/ol.2014.2528
Inoue, A., Ohnishi, T., Kohno, S.,
Nishikawa, M.,
Nishida, N.
and
Ohue, S.
(2016) Role
of Denosumab in Endoscopic Endonasal Treatment for Juvenile Giant Cell Tu- mor:
A Case Report and Review of Literature. World Neurosurgery, 91, 674.e1- 674.e6. https://doi.org/10.1016/j.wneu.2016.04.054
Gupta, R., Mohindra, S., Mahore, A.,
Mathuriya, S.N.
and
Radotra, B.D. (2008) Giant
Cell Tumor of the Clivus. British Journal
of Neurosurgery, 22,
447-449. https://doi.org/10.1080/02688690701818943
Uslu, G.H., Canyilmaz, E., Yoney, A., Aydin, S.,
Sahbaz, A.
and
Sari, A.
(2014) Giant Cell Tumor of the Occipital Bone: A Case Report and Review of
the Literature. Oncology Letters, 8, 151-154. https://doi.org/10.3892/ol.2014.2086
Wang, Y., Honda, K., Susuki, S.
and
Ishikawa, K.
(2006) Giant
Cell Tumor at the Lateral Skull Base. American
Journal of Otolaryngology, 27, 64-67. https://doi.org/10.1016/j.amjoto.2005.05.021
Jada, A.S., Shrivastava, R., Mannan, A.,
Kobets, A.
and
Manolidis, S.
(2015) Rare
Presentation of Giant Cell Tumor in the Auditory Canal: Case Report and Review
of the Literature. Journal of
Neurological Surgery Reports, 76, e65-e71. https://doi.org/10.1055/s-0034-1396656
Thomas, D., Henshaw, R., Skubitz, K.,
Chawla, S.,
Staddon, A.,
Blay, J.Y., et al. (2010) Denosumab
in Patients with Giant-Cell Tumour of Bone: An Open-Label, Phase 2 Study. The Lancet Oncology, 11,
275-280. https://doi.org/10.1016/S1470-2045(10)70010-3
Balke, M., Ahrens, H., Streitbuerger, A.,
Koehler, G.,
Winkerlmann, W.,
Gosheger, G., et al. (2009) Treatment
Options for Recurrent Giant Cell Tumors of Bone. Jour- nal of Cancer Research and
Clinical Oncology, 135,
149-158. https://doi.org/10.1007/s00432-008-0427-x
Roeder, F., Timke, C., Zwicker, F.,
Thieke, C.,
Bischof, M.,
Debus, J., et al. (2010) Intensity
Modulated Radiotherapy (IMRT) in Benign Cell Tumors: A Single Institution Case
Series and Short Review of the Literature. Radiation
Oncology, 5, 18. https://doi.org/10.1186/1748-717X-5-18
Kim, I.Y., Jung, S., Jung, T.Y.,
Moon, K.S., Jang, W.Y.,
Park, S.J., et al. (2012) Gamma
Knife Radiosurgery for Giant Cell Tumor of the Petrous Bone. Clinical Neurology and Neurosurgery, 114,
185-189. https://doi.org/10.1016/j.clineuro.2011.10.007
Saeed, E.F., Tunio, M. and
Gabriela, S.
(2014) Giant
Cell Tumor Of Lumbar Spine Treated with Rapid Arc Intensity Modulated Arc
Therapy: Case Report and Review of Literature. Journal of Cancer Research and Therapeutics, 5, 611-617. https://doi.org/10.4236/jct.2014.56070
Rutkwoski, P.,
Ferrari, S.,
Grimer, R.J.,
Stalley, P.D.,
Dijkstra, S.P.,
Pienkowski, A., et al. (2015) Surgical
Downstaging in a Open-Label Phase II Trial of Denosumab in Patients of Giant
Cell Tumor of Bone. Annals of Surgical
Oncology, 22,
2860-2868. https://doi.org/10.1245/s10434-015-4634-9
Chawla, S., Henshaw, R., Seeger, L.,
Choy, E.,
Blay, J.Y.,
Ferrari, S., et al. (2013) Safety
and Efficacy of Denosumab for Adults and Skeletally Mature Adolescents with
Giant Cell Tumour of Bone: Interim Analysis of an Open-Label, Parallel- Group,
Phase 2 Study. The Lancet Oncology, 14,
901-908. https://doi.org/10.1016/S1470-2045(13)70277-8